Impact of Early ADL Education on Outcomes Post DRF ORIF
Launched by GEORGE WASHINGTON UNIVERSITY · Feb 1, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how early education on daily activities can help people recover after having surgery for a distal radius fracture (a break in the wrist). Participants will be divided into two groups. One group will receive a video and handout that teaches them how to safely perform everyday tasks using the injured wrist while they heal. The other group will watch a video about how to care for their surgical wound and receive standard recovery instructions. Researchers will assess how well each group is doing at various points during their recovery, looking at things like pain levels, wrist movement, and strength.
To participate in this trial, you need to be at least 18 years old, speak English, and have had surgery for your wrist fracture within the last two weeks. However, if you have certain conditions that affect your nerves, cognitive abilities, or if you have multiple injuries, you may not be eligible. If you join the study, you'll learn helpful ways to use your hand as you recover, and your progress will be monitored over time to see the benefits of this early education.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English Speaking DRF treated with ORIF Individuals 18 years of age or older 2 weeks or less post ORIF for DRF
- Exclusion Criteria:
- • Individuals with pre-existing neurological coniditons affecting the upper limb Individuals with congnitive deficits that would limit the ability to correctly report information on outcome measures Individuals with psychological deficits which would limit the ability to correctly report information on outcome measures Individuals with multiple injuries to the affected upper limb Individuals with multiple injuries to both upper limbs Prior distal radius fracture involving the same wrist Individuals receiving hand therapy for another injury at enrollment into study
About George Washington University
George Washington University (GWU) is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, GWU leverages its extensive resources and expertise to facilitate innovative studies that aim to improve healthcare outcomes. The university's commitment to ethical research practices, collaboration with multidisciplinary teams, and engagement with diverse populations underscores its role in addressing critical health challenges. By fostering a rigorous scientific environment, GWU strives to translate research findings into effective clinical applications, ultimately enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported